German pharma firm Stada plans to launch its initial public offering (IPO) as soon as Wednesday, two people familiar with the ...

Stada Arzneimittel AG’s private equity owners are pushing back a planned initial public offering of the German drugmaker ...

A return to the stock exchange however remains the preference, one of the people said. Stada could be valued at around 10 to ...

Private equity funds that own German drugmaker Stada Arzneimittel AG have decided to postpone its planned initial public ...

Stada Arzneimittel AG’s private equity owners are pushing back a planned initial public offering of the German drugmaker until September, people with knowledge of the matter said. Bain Capital ...

German pharmaceutical firm Stada is evaluating all ownership options, potentially considering an initial public offering. This decision follows reports of the company delaying its planned listing ...

German drugmaker Stada Arzneimittel's private-equity owners Bain Capital and Cinven are delaying a planned initial public offering of the company until September due to recent market uncertainties ...

Euronext NV Chief Executive Officer Stephane Boujnah said investors are increasingly moving money to Europe amid prospects ...

Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million, ...

German pharmaceutical company Stada Arzneimittel has delayed its IPO to the third quarter, while in the same country ...